COMP <GO>

HELP vs COLL // DIVIDEND YIELD & FCF PAYOUT SAFETY

Helus Pharma Inc. (NASDAQ) VS. Collegium Pharmaceutical Inc. (NASDAQ) • 15-METRIC TALLY: HELP 1 — COLL 1

■ METRIC PARITY

LAST: $10.71 (-1.83%) • MKT CAP: $782.5M

dividend-safety

0.00%

LAST: $24.03 (+3.44%) • MKT CAP: $782.3M

dividend-safety

0.00%

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HELP VS. COLL) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	HELP	COLL	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	—	59.30%	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	—	85.00%	—	TIE	/roic <GO>
EV/EBITDA & P/E Valuation	—	3.0x	—	TIE	/valuation <GO>
Free Cash Flow Yield	—	—	—	TIE	/fcf-yield <GO>
Operating Margin	—	23.00%	—	TIE	/operating-margins <GO>
Net Profit Margin	—	8.10%	—	TIE	/net-margins <GO>
Revenue Growth (YoY)	—	23.60%	—	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE	0.00%	0.00%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	1.27	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	—	7/9	—	TIE	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	44.7	56.9	-12.20	COLL	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple	—	10.4x	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$782.5M	$782.3M	$179.3K	HELP	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	HELP REV	COLL REV	HELP GROSS %	COLL GROSS %	HELP FCF	COLL FCF
FY 2025	—	$780.6M	—	59.3%	—	$327.6M
FY 2024	—	$631.4M	—	59.8%	—	$203.3M
FY 2023	—	$566.8M	—	—	—	$274.7M

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

HELP // BETA —

COLL // BETA —